Alzheimer disease vaccine (Elan)

N/A

Report date: 2022/09/02 20:00:31

Base Information

Drug NameAlzheimer disease vaccine (Elan)
Drug Alias NameBetablocAN-1792/QS-21Aβ42 vaccineAmyloid-beta42 vaccine - ElanBeta amyloid A4 protein vaccine (Elan) +[7] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesElan PharmaceuticalsPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Llc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A